Bio Protocol Soars Amidst Whale Buying Frenzy, But Overbought Risk Remains

Bio Protocol’s price has surged to a record high, fueled by increased whale accumulation and bullish investor sentiment. The platform’s recent momentum is attributed to the upcoming launch of Aubrai, its first decentralized scientific agent, which aims to advance research in human longevity. 📈 However, this surge comes with a potential risk: Bio Protocol’s price has become overbought, signaling a possible reversal as traders take profits.